Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators.
Risk of disordered eating at the intersection of gender and racial/ethnic identity among U.S. high school students.
Venlafaxine in the treatment of premenstrual dysphoric disorder.
Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Venlafaxine in the treatment of premenstrual dysphoric disorder.
Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol. 2001 Nov; 98(5 Pt 1):737-44.
View in:
PubMed
subject areas
Adult
Cyclohexanols
Double-Blind Method
Female
Humans
Premenstrual Syndrome
Psychiatric Status Rating Scales
Venlafaxine Hydrochloride
authors with profiles
Kimberly A Yonkers MD